| Structure |
Chemical Name |
CAS |
MF |
 |
Intedanib Impurity |
2243396-74-7 |
C31H32N6O6 |
 |
Donepezil Impurity 3 |
1023500-88-0 |
C24H27NO4 |
 |
Fesoterodine Related Impurity 4 |
214601-12-4 |
C22H29NO2 |
 |
Prasugrel Impurity 14 Maleate |
1373350-60-7 |
C24H25BrFNO7S |
 |
Sofosbuvir Impurity 32 |
1157884-58-6 |
C20H17FO6 |
 |
Torsemide Related Compound 1 |
947327-54-0 |
C13H13N3O2S |
 |
Vortioxetine Impurity 3 |
508233-82-7 |
C17H20N2S |
 |
CYCLOPENTYL BENZOATE |
32651-38-0 |
C12H14O2 |
 |
4,5-ジクロロチオフェン-2-カルボン酸 |
31166-29-7 |
C5H2Cl2O2S |
 |
N,O-Dibenzylated formoterol |
43229-70-5 |
C33H36N2O4 |
 |
Entacapone |
|
|
 |
nifedipine iMpurity |
|
C19H22N2O6 |
|
|
Linagliptin Impurity A |
|
|
 |
Etoricoxib Impurity 38 |
887479-63-2 |
C13H17NO2S |
 |
Pemetrexed Impurity 19 |
1644286-36-1 |
C20H21N5O8 |
 |
Dehydropitavastatin ethyl ester |
254452-91-0 |
C27H26FNO4 |
|
|
Empagliflozin Impurity 31 |
|
|
|
|
1,4-bis(4-((1,4,8,11-tetraazacyclotetradecan-4,8,11-trifluoroacetyl- 1-yl)methyl)benzyl)-8,11-difluoroacetyl-1,4,8,11-tetraazacyclotetra decane |
|
|
 |
Imidafenacin Related Compound 10 |
212756-27-9 |
C21H23N3O |
 |
Entacapone Impurity 4 |
1202160-40-4 |
C11H8N2O6 |
![L-Leucine, N-formyl-, (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]tridecyl ester](/CAS/20210111/GIF/1119226-56-0.gif) |
L-Leucine, N-formyl-, (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]tridecyl ester |
1119226-56-0 |
C30H55NO5 |
 |
Itraconazole Impurity 17 |
854372-78-4 |
C14H15Cl2N3O5S |
![sodium (41S,12R,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12, 13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5] naphthyridine-12-carboxylate](/CAS/20211123/GIF/53448-45-6.gif) |
sodium (41S,12R,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12, 13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5] naphthyridine-12-carboxylate |
53448-45-6 |
C20H24N2O3 |
 |
Rivaroxaban Impurity 35 |
2206360-74-7 |
C23H24N4O6 |
 |
Tirofiban hydrochloride monohydrate Impurity 7 |
2250244-28-9 |
C13H19NO5S |
 |
Imidafenacin Related Compound 7 |
191592-57-1 |
C16H13N |
 |
17α-(シアノメチル)エストラ-1,3,5(10)-トリエン-3,17β-ジオール |
16669-06-0 |
C20H25NO2 |
|
|
Cefaclor Impurity 6 |
|
|
 |
Cephalexin Impurity 6 |
|
C16H17N3O4S |
|
|
Pitavastatin Impurity 42 |
|
|
 |
Rocuronium bromide Impurity J |
|
C32H53BrN2O4 |
|
|
Tofacitinib Impurity 72 |
|
|
|
|
Tofacitinib Impurity 81 |
|
|
 |
Topiroxostat Impurity 9 |
2044708-04-3 |
C7H10N6O |
|
|
Vinorelbine EP Impurity C |
|
|
|
|
Aztreonam Impurity 2 |
|
|
 |
Benazepril Impurity E |
|
C24H28N2O5 |
 |
(S)-2-(2-oxo-4-propyl-2,5-dihydro-1H-pyrrol-1-yl)butanamide |
357338-13-7 |
C11H18N2O2 |
|
|
Linagliptin Impurity V |
|
|
 |
methyl 2-(4-(2-chloroethyl)phenyl)-2-methylpropanoate |
1181267-33-3 |
C13H17ClO2 |
 |
(2RS)-1-bromo-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol |
150194-52-8 |
C11H10BrF2N3O |
![(S)-2-(((1R,2S,5S)-2-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamoyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine 5-oxide](/CAS/20180703/GIF/CB93049205.gif) |
(S)-2-(((1R,2S,5S)-2-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamoyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine 5-oxide |
|
C24H30ClN7O5S |
|
|
Etoricoxib Impurity 18 |
|
|
 |
Ibrutinib Impurity 4 |
1807619-68-6 |
C17H12ClN5O |
|
|
Imatinib Impurity 3 |
|
|
|
|
Mirabegron Impurity 16 |
|
|
|
|
Olaparib Impurity 2 |
|
|
 |
Sofosbuvir Impurity 7 |
1884385-12-9 |
C20H19FO6 |
 |
Vonoprazan Impurity 3 |
928325-41-1 |
C17H15F2N3O2S |
|
|
Cinacalcet Impurity 22 |
|
|
|
|
Dapagliflozin Impurity C |
|
|
|
|
Dasatinib Impurity E |
|
|
|
|
Ixazomib Impurity |
|
|
|
|
Nevirapine Impurity |
|
|
|
|
Canagliflozin Impurity 44 |
|
|
|
|
Clotrimazole Impurity 3 |
|
|
 |
Dithio-Desethyl Carbodenafil |
1610830-81-3 |
C22H28N6OS2 |
|
|
Erlotinib Impurity 57 |
|
|
|
|
Oseltamivir Impurity 29 |
|
|
|
|
Pramipexole Impurity 36 |
|
|
 |
Riboflavin Impurity 1 |
64480-68-8 |
C16H20N2O7 |
|
|
Rocuronium Bromide Impurity 10 |
|
|
 |
Rocuronium Bromide Impurity 23 |
|
C23H39NO3 |
|
|
Cefoxitin EP Impurity G |
|
|
|
|
Dextrorotation lansoprazole Impurity L |
|
|
|
|
lansoprazole Impurity 25 |
|
|
|
|
Mirabegron Enantiomer Impurity |
|
|
|
|
Ropivacaine Impurity 44 |
|
|
|
|
Ropivacaine Impurity 7 |
|
|
|
|
Sugammadex sodium Org199010-1 Impurity |
|
|
|
|
Sugammadex sodium Org226100-1 Impurity |
|
|
|
|
Butyphthalide impurity 26 |
|
|
|
|
Butyphthalide impurity 32 |
|
|
|
|
Canagliflozin Impurity 30 |
|
|
 |
Celecoxib Impurity 20 |
343853-74-7 |
C6H7N3O3S |
|
|
Emtricitabine Impurity CFTU1 |
|
|
|
|
Febuxostat Impurity 82 |
|
|
|
|
Febuxostat Impurity 87 |
|
|
|
|
Gefitinib Impurity R |
|
|
 |
Imatinib impurity 31 |
1356565-47-3 |
C17H17N7 |
|
|
LCZ696(valsartan + sacubitril) impurity 33 |
|
|
|
|
Lenvatinib Impurity 26 |
|
|
|
|
Ozagrel impurity C |
|
|
|
|
Regorafenib Impurity 24 |
|
|
|
|
Regorafenib Impurity 32 |
|
|
|
|
Sitafloxacin Impurity ZZ-A-01 |
|
|
 |
Solifenacin impurity 18 |
1243274-83-0 |
C14H17NO3 |
|
|
Tofacitinib Impurity 87 |
|
|
|
|
Tofacitinib Impurity 92 |
|
|
 |
Amlodipine EP Impurity K |
|
C26H31ClN2O8S |
|
|
Febuxostat Impurity 49 |
|
|
 |
Budesonide Impurity 6 |
131918-73-5 |
C21H26O6 |
 |
Omarigliptin Impurity |
1819364-01-6 |
C16H18F2N4O |
 |
Palbociclib Impurity 8 |
827022-31-1 |
C31H41N7O4 |
 |
Sitagliptin EP Impurity C |
1345822-86-7 |
C16H19F5N5O5P |
 |
Trifluridine Impurity |
2086328-10-9 |
C10H11F3N2O5 |
|
|
Valsartan related compound H |
|
|
 |
Vildagliptin Related Compound H |
2253194-13-5 |
C12H16N4O |
|
|
Moxifloxacin Impurity 7 |
|
|
![(R)-6-Benzyloxy-8-(oxiran-2-yl)-4H-benzo[1,4]oxazin-3-one](/CAS/20180703/GIF/869478-12-6.gif) |
(R)-6-Benzyloxy-8-(oxiran-2-yl)-4H-benzo[1,4]oxazin-3-one |
869478-12-6 |
C17H15NO4 |